Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantation.
Ishigami M, Honda T, Okumura A, Ishikawa T, Kobayashi M, Katano Y, Fujimoto Y, Kiuchi T, Goto H. Ishigami M, et al. Among authors: ishikawa t. J Gastroenterol. 2008;43(5):363-8. doi: 10.1007/s00535-008-2168-7. Epub 2008 Jul 1. J Gastroenterol. 2008. PMID: 18592154
Hypofractionated stereotactic body radiotherapy for primary and metastatic liver tumors using the novalis image-guided system: preliminary results regarding efficacy and toxicity.
Iwata H, Shibamoto Y, Hashizume C, Mori Y, Kobayashi T, Hayashi N, Kosaki K, Ishikawa T, Kuzuya T, Utsunomiya S. Iwata H, et al. Among authors: ishikawa t. Technol Cancer Res Treat. 2010 Dec;9(6):619-27. doi: 10.1177/153303461000900610. Technol Cancer Res Treat. 2010. PMID: 21070084 Free article. Clinical Trial.
[A case of intractable hepatic encephalopathy successfully treated by oral administration of vancomycin hydrochloride, with subsequent improvement of hepatic function reserve enabling transcatheter arterial chemoembolization against hepatocellular carcinoma].
Kuzuya T, Takeda K, Utsunomiya S, Taga M, Kawata N, Ikeda T, Imai N, Mizutani Y, Hirose K, Ishikawa T. Kuzuya T, et al. Among authors: ishikawa t. Gan To Kagaku Ryoho. 2011 Jun;38(6):995-7. Gan To Kagaku Ryoho. 2011. PMID: 21677494 Japanese.
Prevalence of hepatitis C virus genotype 1a in Japan and correlation of mutations in the NS5A region and single-nucleotide polymorphism of interleukin-28B with the response to combination therapy with pegylated-interferon-alpha 2b and ribavirin.
Hayashi K, Katano Y, Kuzuya T, Tachi Y, Honda T, Ishigami M, Itoh A, Hirooka Y, Ishikawa T, Nakano I, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishikawa t. J Med Virol. 2012 Mar;84(3):438-44. doi: 10.1002/jmv.23207. J Med Virol. 2012. PMID: 22246829
Comparison of the efficacy of ribavirin plus peginterferon alfa-2b for chronic hepatitis C infection in patients with and without coagulation disorders.
Honda T, Katano Y, Kuzuya T, Hayashi K, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Toyoda H, Kumada T, Yamamoto K, Matsushita T, Kojima T, Takamatsu J, Goto H. Honda T, et al. Among authors: ishikawa t. J Med Virol. 2013 Feb;85(2):228-34. doi: 10.1002/jmv.23444. Epub 2012 Nov 14. J Med Virol. 2013. PMID: 23160930
Pegylated interferon monotherapy in patients with chronic hepatitis C with low viremia and its relationship to mutations in the NS5A region and the single nucleotide polymorphism of interleukin-28B.
Hayashi K, Katano Y, Masuda H, Ishizu Y, Kuzuya T, Honda T, Ishigami M, Itoh A, Hirooka Y, Nakano I, Ishikawa T, Urano F, Yoshioka K, Toyoda H, Kumada T, Goto H. Hayashi K, et al. Among authors: ishikawa t. Hepatol Res. 2013 Jun;43(6):580-8. doi: 10.1111/hepr.12005. Epub 2013 Jan 29. Hepatol Res. 2013. PMID: 23356752
7,636 results